Meticrane

CARDIOVASCULAR SYSTEM

Key facts

Meticrane is a drug catalogued in DrugCentral. Recorded indications include Hypertensive disorder.

• Indications: Hypertensive disorder.
• ATC code: C03BA09 (Sulfonamides, plain).
• Molecular formula: C10H13NO4S2; molecular weight 275.35 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Hypertensive disorder

ATC classification

ATC code	Therapeutic hierarchy
C03BA09	CARDIOVASCULAR SYSTEM › DIURETICS › LOW-CEILING DIURETICS, EXCL. THIAZIDES › Sulfonamides, plain

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Meticrane is on its molecule page.

• Molecular formula: C₁₀H₁₃NO₄S₂
• Molecular weight: 275.35 g/mol
• CAS number: —
• InChIKey: FNQQBFNIYODEMB-UHFFFAOYSA-N
• PubChem CID: 4165

CC1=C(C=C2C(CCCS2(=O)=O)=C1)S(N)(=O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Meticrane used for?

DrugCentral lists the following indications for Meticrane: Hypertensive disorder.

What is the chemical formula of Meticrane?

Meticrane has the molecular formula C10H13NO4S2 and a molecular weight of 275.35 g/mol.

Sources

• DrugCentral drug card 1777 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1318341 — compound record and bioactivity
• PubChem CID 4165 — chemical identifiers
• DrugBank DB13284 — drug record
• FDA UNII I7EKN1924Q — substance identity

How this page is built: methodology · editorial policy & corrections.